FDA
approval
· 2026-03-05
FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
Summary
The FDA approved a supplemental application for Children's XYZAL Allergy (levocetirizine dihydrochloride) from Chattem, Inc., signaling a label update or expans…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)